The world has changed since Sanofi in February unveiled its intention to spin off its API production operations in Europe, but the company is still pressing ahead with the split, sources told Reuters.
Sanofi will start prepping this fall for a stock market listing of the new company by 2022 and is discussing the business with potential investors, including France’s state investment bank, sources told the news service.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,